Pot Stocks Start 2019 With a Bang

Together with Grizzle, Civilized provides a weekly unique look at the growing cannabis market, in our cannabis sector investment show All Time Highs. Grizzle illuminates the opportunities and guides you through the challenges of this new sector, by identifying the opportunities and risks for the new industry, from a ‘big picture’ perspective to actionable, cash-generating ideas. 

This week, the President of Grizzle - Thomas George - discusses how cannabis stocks have been on a tear in 2019 as the industry keeps growing up. Heading in a different direction, whole flower prices are on a steady decline, but producers are getting more efficient manufacturing at scale, and retail prices for edibles and concentrates are holding steady. An analyst is also predicting the Canadian supply shortage will last up to three years, which Grizzle thinks will be resolved by the end of the year. For more answers on cannabis stocks and businesses, remember to send in your questions.


On Flatbush Avenue, tucked amidst the nexus of four iconic Brooklyn neighborhoods (Park Slope, Boerum Hill, Fort Greene, and Prospect Heights), medical cannabis company Citiva opened up their newest location at the turn of the new year. Walking through the shiny glass door, you’re first struck by the sleek tidiness of the front lobby. Both the dispensary's resident pharmacist and receptionist greet visitors as they clear patients (as does any medical dispensary in the country) before allowing them through to the retail room.

Can we see some ID please?

You must be 19 years of age or older to enter.